°Ç¸ç³Ô¹Ï

Skip to main content
Guidance

MenB vaccine (Bexsero®) offer Autumn 2026: PGD template

Patient group direction (PGD) template to support the national meningococcal group B (Bexsero®) vaccination one-off, time-limited offer Autumn 2026 programme.

Applies to England

Documents

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Following the unprecedented MenB outbreak primarily among University of Kent students in March 2026, and Weymouth and Reading clusters more recently, the patient group direction (PGD) is to support the administration of ²Ñ±ð²ÔµþÌý±¹²¹³¦³¦¾±²Ô±ðÌýfor a one-off, time-limited, targeted vaccination programme (see Bipartite letter).

²Ñ±ð²ÔµþÌý±¹²¹³¦³¦¾±²Ô±ðÌýPGD version 1.0 is valid from 24 June 2026 to 31 March 2027.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see ). Practitioners should follow local policy and procedures to access authorised PGDÌý»å´Ç³¦³Ü³¾±ð²Ô³Ù²õ.

°Õ³ó¾±²õÌýPGD template should be used with reference to current national guidance, the Green Book, and  for the vaccine.

Updates to this page

Published 25 June 2026

Sign up for emails or print this page